T E Rix. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Abdominal Neoplasms/complicationsAbdominal Neoplasms/therapyAdenomatous Polyposis Coli/complicationsAntineoplastic Agents/adverse effectsFibromatosis, Aggressive/complicationsFibromatosis, Aggressive/therapyHumansSulindac/adverse effectsTamoxifen/adverse effectsTreatment Outcome
Substances: See more » Antineoplastic AgentsTamoxifenSulindac
Year: 2007 PMID: 17256816 DOI: 10.1002/bjs.5773
Source DB: PubMed Journal: Br J Surg ISSN: 0007-1323 Impact factor: 6.939